Report Content

Chapter 1.  Methodology & Scope

1.1.  Definition and forecast parameters

1.1.1.  Definitions

1.1.2.  Methodology and forecast parameters

1.2.  Data sources            

1.2.1.  Secondary

1.2.2.  Primary

Chapter 2.  Executive Summary

2.1.  India platelet and plasma industry 360⁰ synopsis, 2013 – 2024

2.1.1.  Country trends

2.1.2.  Component trends

2.1.3.  Distribution channel trends

2.1.4.  Application trends

Chapter 3.  Industry Insights

3.1.  Industry segmentation

3.2.  Industry landscape, 2013 - 2024

3.3.  Major factor analysis

3.3.1.  Drivers

3.3.1.1.   Increasing prevalence of liver diseases in elderly population

3.3.1.2.   Rise in the number of blood transfusions

3.3.1.3.   Exclusive use of plasma for treatment of rare disease

3.3.2.  Industry pitfalls and challenges

3.3.2.1.   Stringent regulatory policies

3.3.2.2.   Affordability issue due to high costs

3.4.  Porter’s analysis

3.5.  Competition review, 2017

3.6.  PEST analysis

Chapter 4.     India Platelet and Plasma Market, By Component

4.1.  Key trends in India platelet and plasma market, by component

4.1.1.  Market estimates and forecast, by component, 2013-2024 (USD Million)

4.2.  Platelets

4.3.  Plasma

Chapter 5.     India Platelet and Plasma Market, By Application

5.1.  Key trends in India platelet and plasma market, by application

5.1.1.  Market estimates and forecast, by application, 2013-2024 (USD Million)

5.2.  Hemophilia

5.3.  Thrombocytopenia

5.4.  Perioperative indications

5.5.  Platelet function disorders

5.6.  Coagulation factor deficiencies

5.7.  Thrombotic thrombocytopenia purpura

5.8.  Hemorrhage

5.9.  Liver disease

Chapter 6.     India Platelet and Plasma Market, By Distribution Channel

6.1.  Key trends in India platelet and plasma market, by distribution channel

6.1.1.    Market estimates and forecast, by distribution channel, 2013 – 2024 (USD Million)

6.2.  Hospitals

6.3.  Ambulatory Surgical Centers

Chapter 7.  Company Profiles

7.1.  Exactech Inc.

7.1.1.  Business overview

7.1.2.  Financial data

7.1.3.  Product landscape

7.1.4.  Strategic outlook

7.2.  Harvest Terumo BCT

7.2.1.  Business overview

7.2.2.  Financial data

7.2.3.  Product landscape

7.2.4.  Strategic outlook

7.3.  PlasmaGen Biosciences

7.3.1.  Business overview

7.3.2.  Financial data

7.3.3.  Product landscape

7.3.4.  Strategic outlook

7.4.  Johnson & Johnson (DePuy Synthes)

7.4.1.  Business overview

7.4.2.  Financial data

7.4.3.  Product landscape

7.4.4.  Strategic outlook

7.5.  Nuo Therapeutics, Inc.

7.5.1.  Business overview

7.5.2.  Financial data

7.5.3.  Product landscape

7.5.4.  Strategic outlook

7.6.  Regen Lab SA

7.6.1.  Business overview

7.6.2.  Financial data

7.6.3.  Product landscape

7.6.4.  Strategic outlook

7.7.  Stryker

7.7.1.  Business overview

7.7.2.  Financial data

7.7.3.  Product landscape

7.7.4.  Strategic outlook

7.8.  Zimmer Biomet Holdings, Inc

7.8.1.  Business overview

7.8.2.  Financial data

7.8.3.  Product landscape

7.8.4.  Strategic outlook

7.9.  Indian Red Cross Society

7.9.1.  Business overview

7.9.2.  Financial data

7.9.3.  Product landscape

7.9.4.  Strategic outlook

Data Tables

TABLE 1.  India platelet and plasma industry 360⁰ synopsis, 2013 – 2024

TABLE 2.  Processing charges for blood components issued by NBTC

TABLE 3.  India platelet and plasma market size, by component, 2013 – 2024 (USD Million)

TABLE 4.  India platelet and plasma market, by application, 2013 - 2024, (USD Million)

TABLE 5.  India platelet and plasma market, by distribution channel, 2013 - 2024, (USD Mn)

Charts & Figures

FIG 1.   Industry segmentation

FIG 2.   India platelet and plasma market, 2013 – 2024 (USD Million)

FIG 3.   Value chain analysis

FIG 4.   Growth potential analysis, by component

FIG 5.   Growth potential analysis, by application

FIG 6.   Growth potential analysis, distribution channel

FIG 7.   Porter’s analysis

FIG 8.   Strategy Dashboard

FIG 9.   PESTEL analysis